Literature DB >> 28143762

Altered reward anticipation: Potential explanation for weight gain in schizophrenia?

Oliver Grimm1, Stefan Kaiser2, Michael M Plichta3, Philippe N Tobler4.   

Abstract

Obesity and weight gain are severe complications of mental illness, especially schizophrenia. They result from changes in lifestyle and nutrition, side effects of medication and other, less well-understood factors. Recent studies suggest that obesity and weight gain are linked to psychopathology. Specifically, severe psychopathology is associated with greater weight dysregulation, typically weight gain. However, our knowledge about the neuroscientific basis of weight gain in schizophrenia is currently limited. We propose that altered reward anticipation, which in turn is related to striatal dopaminergic dysregulation, may explain why obesity is more prevalent in individuals with mental illness. We review evidence that reward anticipation and weight change are linked by a core deficit in dopaminergic striatal circuits. Several lines of evidence, running from animal studies to preclinical and clinical studies, suggest that striatal dopaminergic neurotransmission is a major hub for the regulation of eating behavior and that dopamine links eating behavior to other motivated behavior. From this perspective, the present review outlines a unifying perspective on dopaminergic reward anticipation as a theoretical frame to link weight gain, medication effects and psychopathology. We derive important but open empirical questions and present perspectives for new therapeutic concepts.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28143762     DOI: 10.1016/j.neubiorev.2017.01.029

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  4 in total

1.  Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study.

Authors:  Bing Cao; Dongfang Wang; Zihang Pan; Elisa Brietzke; Roger S McIntyre; Natalie Musial; Rodrigo B Mansur; Mehala Subramanieapillai; Jing Zeng; Ninghua Huang; Jingyu Wang
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 6.222

2.  Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment.

Authors:  Shih-Hsien Lin; Huai-Hsuan Tseng; Hsin Chun Tsai; Mei Hung Chi; I Hui Lee; Po See Chen; Kao Chin Chen; Yen Kuang Yang
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

3.  Weight loss induced by quetiapine in a 22q11.2DS patient.

Authors:  Caroline Demily; Alice Poisson; Florence Thibaut; Nicolas Franck
Journal:  Mol Genet Metab Rep       Date:  2017-10-17

4.  Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis.

Authors:  Faith Borgan; Owen O'Daly; Karen Hoang; Mattia Veronese; Dominic Withers; Rachel Batterham; Oliver Howes
Journal:  JAMA Netw Open       Date:  2019-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.